Pallas Capital Advisors LLC Moderna, Inc. Transaction History

Pallas Capital Advisors LLC

  • $2.37 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022
SELL
$126.46 - $235.05 $818,069 - $1.52 Million
-6,469 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$225.82 - $368.51 $521,644 - $851,258
-2,310 Reduced 26.31%
6,469 $1.04 Million
Q3 2021

Nov 12, 2021
BUY
$221.9 - $484.47 $1.95 Million - $4.25 Million
8,779 New
8,779 $3.04 Million

Others Institutions Holding MRNA

# of Institutions
953
Shares Held
240M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email